Department of Cardiothoracic and Vascular Surgery, McGovern Medical School, The University of Texas Health Science Center at Houston, 6400 Fannin Street, Suite 2850, Houston, TX, 77030, USA.
Center for Clinical Research and Evidence-Based Medicine, Department of Pediatrics, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.
BMC Med Res Methodol. 2023 Apr 29;23(1):107. doi: 10.1186/s12874-023-01931-7.
Research on risk factors for neuropsychiatric adverse events (NAEs) in smoking cessation with pharmacotherapy is scarce. We aimed to identify predictors and develop a prediction model for risk of NAEs in smoking cessation with medications using Bayesian regularization.
Bayesian regularization was implemented by applying two shrinkage priors, Horseshoe and Laplace, to generalized linear mixed models on data from 1203 patients treated with nicotine patch, varenicline or placebo. Two predictor models were considered to separate summary scores and item scores in the psychosocial instruments. The summary score model had 19 predictors or 26 dummy variables and the item score model 51 predictors or 58 dummy variables. A total of 18 models were investigated.
An item score model with Horseshoe prior and 7 degrees of freedom was selected as the final model upon model comparison and assessment. At baseline, smokers reporting more abnormal dreams or nightmares had 16% greater odds of experiencing NAEs during treatment (regularized odds ratio (rOR) = 1.16, 95% credible interval (CrI) = 0.95 - 1.56, posterior probability P(rOR > 1) = 0.90) while those with more severe sleep problems had 9% greater odds (rOR = 1.09, 95% CrI = 0.95 - 1.37, P(rOR > 1) = 0.85). The prouder a person felt one week before baseline resulted in 13% smaller odds of having NAEs (rOR = 0.87, 95% CrI = 0.71 - 1.02, P(rOR < 1) = 0.94). Odds of NAEs were comparable across treatment groups. The final model did not perform well in the test set.
Worse sleep-related symptoms reported at baseline resulted in 85%-90% probability of being more likely to experience NAEs during smoking cessation with pharmacotherapy. Treatment for sleep disturbance should be incorporated in smoking cessation program for smokers with sleep disturbance at baseline. Bayesian regularization with Horseshoe prior permits including more predictors in a regression model when there is a low number of events per variable.
关于药物戒烟治疗中神经精神不良事件(NAE)风险因素的研究很少。我们旨在使用贝叶斯正则化来确定预测因子,并开发一个用于药物戒烟治疗中 NAE 风险的预测模型。
贝叶斯正则化通过在 1203 名接受尼古丁贴片、伐伦克林或安慰剂治疗的患者数据上应用两种收缩先验,即马蹄铁和拉普拉斯,应用于广义线性混合模型。考虑了两个预测因子模型来分离心理社会工具中的总结得分和项目得分。总结得分模型有 19 个预测因子或 26 个哑变量,项目得分模型有 51 个预测因子或 58 个哑变量。共研究了 18 个模型。
在模型比较和评估后,选择了具有马蹄铁先验和 7 个自由度的项目得分模型作为最终模型。在基线时,报告更多异常梦境或噩梦的吸烟者在治疗期间发生 NAE 的可能性增加 16%(正则化优势比(rOR)= 1.16,95%可信区间(CrI)= 0.95-1.56,后验概率 P(rOR>1)= 0.90),而睡眠问题更严重的吸烟者发生 NAE 的可能性增加 9%(rOR=1.09,95%CrI=0.95-1.37,P(rOR>1)= 0.85)。一个人在基线前一周感到自豪的程度降低了 13%发生 NAE 的可能性(rOR=0.87,95%CrI=0.71-1.02,P(rOR<1)= 0.94)。不同治疗组的 NAE 发生率相当。最终模型在测试集中表现不佳。
在药物戒烟治疗中,基线时报告的更差的睡眠相关症状导致 NAE 发生的可能性增加了 85%-90%。对于基线时存在睡眠障碍的吸烟者,应在戒烟计划中纳入睡眠障碍治疗。具有马蹄铁先验的贝叶斯正则化允许在每个变量的事件数较少的情况下,在回归模型中包含更多的预测因子。